Maria Helena Sarragiotto

Dr. Maria Helena Sarragiotto


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PBPaula Baréa
Paula Baréa
VBValéria Aquilino Barbosa
Valéria Aquilino Barbosa
DBDanielle Lazarin Bidóia
Danielle Lazarin Bidóia
JPJéssica Carreira de Paula
Jéssica Carreira de Paula
TSTalitha Fernandes Stefanello
Talitha Fernandes Stefanello
MSMaria Helena Sarragiotto
Maria Helena Sarragiotto

1 November 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
VBValéria Aquilino Barbosa
Valéria Aquilino Barbosa
PBPaula Baréa
Paula Baréa
RMRenata Sespede Mazia
Renata Sespede Mazia
TUTania Ueda-Nakamura
Tania Ueda-Nakamura
WCWillian Ferreira da Costa
Willian Ferreira da Costa
MSMaria Helena Sarragiotto
Maria Helena Sarragiotto

1 December 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
FSFranciele Cristina Savariz
Franciele Cristina Savariz
MFMary Ann Foglio
Mary Ann Foglio
ARAna Lucia Tasca Gois Ruiz
Ana Lucia Tasca Gois Ruiz
WCWillian Ferreira da Costa
Willian Ferreira da Costa
MSMarina de Magalhães Silva
Marina de Magalhães Silva
MSMaria Helena Sarragiotto
Maria Helena Sarragiotto

21 May 2012 in Molecules
Verified
Journal Article
Open access
PDF file
FSFranciele Cristina Savariz
Franciele Cristina Savariz
MFMary Ann Foglio
Mary Ann Foglio
JCJoão Ernesto De Carvalho
João Ernesto De Carvalho
ARAna Lucia Tasca Gois Ruiz
Ana Lucia Tasca Gois Ruiz
MDMarta Cristina Teixeira Duarte
Marta Cristina Teixeira Duarte
MSMaria Helena Sarragiotto
Maria Helena Sarragiotto
In the present work, we report the synthesis and in vitro anticancer and antimicrobial activity evaluation of a new series of 1-substituted-β-carboline derivatives bearing a 4-benzylidene-4H-oxazol-5-one unity at C-3. The compound 2-[1-(4-methoxyphenyl)-9H-β-carbolin-3-yl]-4-(benzylidene)-4H-oxazol-5-one (11) was the most active derivative, exhibiting a potent cytotoxic activity against glioma (U251), prostate (PC-3) and ovarian (OVCAR-03) cancer cell lines with IC50 values of 0.48, 1.50 and 1.07 µM, respectively. An in silico study of the ADME properties of the novel synthesized β-carboline derivatives was also performed.

1 January 2010 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Open access
PDF file
FSFranciele C. Savariz
Franciele C. Savariz
AFAnelise S. N. Formagio
Anelise S. N. Formagio
VBValéria A. Barbosa
Valéria A. Barbosa
MFMary Ann Foglio
Mary Ann Foglio
JCJoão E. de Carvalho
João E. de Carvalho
MSMaria Helena Sarragiotto
Maria Helena Sarragiotto
With the purpose of activity enhancement of 1-substituted phenyl-3-(2-thioxo-1,3,4-oxadiazol-5-yl) β-carbolines 1a-c, reported as potential antitumor agents in our previous study, herein we report the synthesis and antitumor activity evaluation of several novel Mannich bases 2-7(a-c), by the introduction of different alkylamino(methyl) groups in the 1,3,4-oxadiazole unity of 1a-c. The antimicrobial activities of 1a-c and of 2-7(a-c) were also evaluated. Additionally, an in silico study of the ADME properties of novel synthesized β-carboline derivatives 2-7(a-c) was performed by evaluation of their Lipinski's parameters and topological polar surface area (TPSA) and percentage of absorption (% ABS) data.

1 November 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
HVHélito Volpato
Hélito Volpato
DSDébora Botura Scariot
Débora Botura Scariot
ESEdna Soares
Edna Soares
AJAndrey Petita Jacomini
Andrey Petita Jacomini
FRFernanda Rosa
Fernanda Rosa
MSMaria Do Céu Sousa
Maria Do Céu Sousa